Lexaria Bioscience Corp. (NASDAQ: LEXX) will be presenting at the Benzinga Global Small Cap Conference taking place on December 8-9, 2021. We invite our shareholders and all interested parties to explore investment opportunities within the global small cap space.
Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/december-2021-global/.
About the Benzinga Global Small Cap Conference
The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined educational modules, take a look at a curated group of small cap investment opportunities, and connect with the global small cap audience in an intimate, virtual setting.
For more information and/or to register for the conference please visit: https://www.benzinga.com/events/small-cap/december-2021-global/.
We look forward to seeing you there.
For further information:
Lexaria Bioscience Corp.
George Jurcic
250-765-6424, ext 202
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.lexariabioscience.com
Last Trade: | US$0.86 |
Daily Change: | -0.03 -3.87 |
Daily Volume: | 244,850 |
Market Cap: | US$19.050M |
September 29, 2025 September 26, 2025 September 19, 2025 August 14, 2025 July 28, 2025 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load